confirmed CCyR

Related by string. * confi rmed . confi rm . confi rms . confirms . confirming . Confirms . Confirmed . Confirming . Confirm . CONFIRMS : RANGE VOL KANSAS CONFIRMED . Release Date Confirmed . Buyers Must Confirm . Study Confirms . WT AVG KANSAS CONFIRMED . Confirmed speakers . reported NEBRASKA CONFIRMED . Confirmed myNR members . Autopsy confirms / : achieved CCyR . CCyR . response CCyR * *

Related by context. Frequent words. (Click for all words.) 66 Secondary endpoints included 66 cytogenetic response 66 Montgomery Asberg Depression 64 annualized relapse 63 Secondary endpoints include 63 Response Evaluation Criteria 62 ACR# response 62 prospectively defined 62 RECIST criteria 62 complete cytogenetic 61 % CI #.#-#.# [003] 61 Expanded Disability Status 60 HbA1C 60 sustained virologic response 59 estimated glomerular filtration 59 mucosal healing 59 Alzheimer Disease Assessment 59 mg QD 59 HSCT 59 XIENCE V vs. 59 Secondary endpoints 59 events MACE 59 free survival PFS 58 TAXUS p value 58 plus methotrexate 58 biochemical recurrence 58 ADAS cog 58 seroprotection 58 sensitivity specificity 58 evaluable 58 plus dexamethasone 58 Negative Syndrome 58 mg BID 57 Median survival 57 neoadjuvant 57 #mg/day [001] 57 median PFS 57 prespecified 57 Solid Tumors 57 undetectable HCV RNA 57 platelet reactivity 56 carotid intima media 56 Pharmacokinetic 56 Arch Intern Med 56 ADHD RS 56 erythrocyte sedimentation rate 56 patients evaluable 56 systemic embolism 56 plus prednisone 56 Engerix B 56 repeat revascularization 56 virologic failure 56 virologic response 56 univariate 56 placebo p = 56 CI -#.# 56 DAS# [002] 56 IPSS 55 achieved statistical significance 55 % CI #.#-#.# [007] 55 glycated hemoglobin 55 mg kg belimumab 55 tirofiban 55 secondary efficacy endpoints 55 HbA1c levels 54 preoperatively 54 cerebrovascular events 54 mg kg dose 54 RECIST 54 mcg kg 54 rehospitalization 54 DOXIL 54 evaluable patients 54 HbA 1c 54 Thrombolysis 54 median CD4 54 distant metastasis 54 laboratory abnormalities 54 placebo p 54 Main Outcome Measures 54 Disease Activity 54 serum PSA 54 μmol L 54 nonsignificant 54 LVEF 54 glycosylated hemoglobin 54 coronary revascularization 54 univariate analysis 54 stroke myocardial infarction 53 nonadherence 53 febrile neutropenia 53 chlorambucil 53 SEI Software 53 % CI #.#-#.# [006] 53 Pegasys ® 53 peginterferon 53 serum uric acid 53 hemoglobin A1C 53 CI #.#-#.# [002] 53 confidence interval #.#-#.# 53 serum phosphorus

Back to home page